BSE Code: SUPRIYA
The Supriya Lifescience IPO will be open for bidding on 16th Dec 2021 and will end on 20th Dec 2021. Anchor investors can start bidding on 15th Dec 2021, as per the company.
The IPO price range is issued at Rs. 265 to Rs. 274 per equity share. Bids can be made for a minimum of 1 lot or 54 equity shares or a maximum of 13 lots or 702 equity shares.
The company plans to raise funds accumulating up to ₹700 crores. The Supriya Lifescience IPO has a fresh issue of equity shares aggregating up to Rs. 200 Cr.
The main objective from the fresh issue will be used for funding capital expenditure requirements, repaying debt, and general corporate purposes.
Qualified institutional buyers (QIB) have been reserved 75% of the issue size, 15% for non-institutional investors and 10% is reserved for retail investors.
Supriya Lifescience is one of the key manufacturers and suppliers of active pharmaceutical ingredients (APIs) focusing mainly on research and development.
The data till October 31st, 2021 quotes “the company has product offerings of 38 APIs focused on diverse therapeutic segments such as analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic”.